“eli-lilly” Archives

in
Entry Author Date Location
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More 09/09/19 National
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss 09/03/19 Boston
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Xcelerate at Biotech Week Boston Discount Ticket Sale Ends Friday 08/21/19 National
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint 08/20/19 Indiana
AbbVie’s Successor to Humira Wins FDA OK for Rheumatoid Arthritis 08/16/19 National
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Trump Kills His Administration’s Plan to End Secret Drug Rebates 07/11/19 National
Colorectal Cancer Data Spurs Pfizer to Pay $11.4B for Array Bio 06/17/19 Boulder/Denver
Bio Roundup: Roche-Spark Drags On, GSK Taps CRISPR, Diabetes News & More 06/14/19 National
Can AI Tools, $76M Lead BlackThorn to Targeted Psych Drugs? 06/13/19 San Francisco
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
ASCO Abstracts: Breast Cancer, Precision Treatments in the Spotlight 05/16/19 National
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials 05/09/19 National
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments 05/03/19 National
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Avidity Biosciences Gets $35M in Immunology R&D Deal with Eli Lilly 04/24/19 San Diego
Teva’s Approved Migraine Drug Fails Again to Blunt Rarer Headache 04/23/19 New York
Turning Point Prices IPO, Raising $166M to Test Cancer Drugs 04/17/19 San Diego
Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs 03/22/19 San Diego
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Bio Roundup: Gottlieb Exits, Bristol Defends, Biogen Buys & More 03/08/19 National
Lilly to Launch “Authorized Generic” Insulin Priced at 50% Discount 03/04/19 Indiana
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Bayer Snaps Up Rights to Two Cancer Drugs from Lilly’s $8B Loxo Deal 02/15/19 Indiana
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans 02/12/19 National
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More 02/08/19 National
Page 1 of 19 next page »